Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03052608 |
|---|---|
| Brief Title: | A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC |
| First Submitted : | January 20, 2017 |
| First Submitted that Met QC Criteria : | February 9, 2017 |
| First Posted : | February 14, 2017 |
| Results First Submitted : | March 5, 2021 |
| Results First Submitted that Met QC Criteria : | March 5, 2021 |
| Results First Posted : | April 1, 2021 |
| Last Update Submitted that Met QC Criteria : | February 14, 2024 |
| Last Update Posted : | February 20, 2024 |